PROSPR
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Feb 2025)
What this means for you
This application is over — abandoned 22 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97209650
- Mark type
- Stylized text
- Filed
- 09 Jan 2022
- Published for opposition
- 27 Dec 2022
- Abandoned
- 22 Feb 2025
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; Assays for research purposes; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, precursors for in vitro genetic engineering use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Proteins for the food industry; Proteins for use in manufacture; Catalysts for chemical and biochemical processes; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Enzymes for use in protein hydrolysis; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
- Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medical use; Protein arrays for diagnosing infectious diseases; Protein arrays for diagnosing cancer; Protein arrays for diagnosing chronic diseases; Protein arrays for medical diagnosis purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes
- Class 010 — Medical apparatus: Apparatus for DNA and RNA testing for medical purposes; Apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; Diagnostic apparatus for the detection of cancer; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Flow cytometers for medical diagnostic uses; Genetic testing apparatus for medical purposes; Immunochemical testing apparatus for medical use; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for testing protein, antibody biomarkers; Medical diagnostic apparatus for testing phenotypic biomarkers incorporating recorded operating system software; Medical diagnostic apparatus for testing protein binding and interactions incorporating recorded software for kinetic analysis; Medical instruments, namely, biosensors for detecting infectious diseases; Organoleptic diagnostic testing apparatus for medical, dental or cosmetic use; Sample preparation device for medical diagnostic uses
Owner
- INanoBio Inc, Scottsdale, AZ, US
- INanoBio Inc, Scottsdale, AZ, US
Prosecution history
- 30 Jul 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Jul 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2024 — SOU EXTENSION 3 GRANTED
- 20 Aug 2024 — SOU EXTENSION 3 FILED
- 20 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2024 — SOU EXTENSION 2 GRANTED
- 16 Feb 2024 — SOU EXTENSION 2 FILED
- 16 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2023 — SOU EXTENSION 1 GRANTED
- 17 Aug 2023 — SOU EXTENSION 1 FILED
- 17 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT